Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

Essex BioTech

WebsiteLinkedIncbCrunchbase
Status
INACTIVE
Global HQ
Hong Kong
Countries of investment
  • Hong Kong
Investment stages
  • Seed
Industries
  • Biotechnology
  • Health Tech
  • AI
About
EssexBio is a global bio pharmaceutical company focused on Dermatology, Oncology, Ophthalmology, and Wound Healing, with a strong R&D presence and a wide range of products in over 10,000 hospitals.
Min check size
$500K
Max check size
$2M
Fund size
NPS

Investment Thesis

Essex BioTechnology focuses on the development, manufacturing, and commercialization of genetically engineered therapeutic drugs, particularly for the treatment of surface wounds and eye wounds.
Lead investor
Co Invest
Number of exits
Preferred contact method

Portfolio

Wuhan Adv. Dental Bio-Technology

UNO Medical Group

Antikor Biopharma

Mitotech S.A.

Henlius

Humacyte

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp